Get 40% Off
💰 Buffett reveals a $6.7B stake in Chubb. Copy the full portfolio for FREE with InvestingPro’s Stock Ideas toolCopy Portfolios

Can Patterson Companies (PDCO) Surprise In Q4 Earnings?

Published 05/22/2016, 09:32 PM
Updated 07/09/2023, 06:31 AM
PDCO
-
LH
-
AIRM
-
CNMD
-

Patterson Companies Inc. (NASDAQ:PDCO) is set to announce fourth-quarter fiscal 2016 earnings on May 26. Last quarter, the company reported earnings of 68 cents per share which beat the Zacks Consensus Estimate by a penny.

However, we note that the company has posted an average negative surprise of 3.38% over the last four quarters.

PATTERSON COS Price and Consensus

PATTERSON COS Price and Consensus | PATTERSON COS Quote

Let’s find out how things are shaping up for this quarter.

Factors at Play

Post the release of third-quarter fiscal 2016 results, Patterson Companies narrowed its adjusted earnings projection to the range of $2.42 to $2.48 per share from the previous band of $2.40–$2.50.

Although prospects of the dental and companion animals market is encouraging, sluggish growth projection for the production animal market is a concern. Nevertheless, Patterson Companies expects higher sales from CEREC, driven by the introduction of the new product (Zirconia) and growing international sales.

However, lack of operating margin expansion opportunities will hurt earnings, in our view.

Earnings Whispers

Our proven model does not conclusively show that Patterson Companies is likely to beat earnings this quarter. That is because a stock needs to have both a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) for this to happen. That is not the case here as you will see below.

Zacks ESP: Patterson Companies has a Zacks ESP of 0.00%. That is because both the Most Accurate estimate and the Zacks Consensus Estimate stand at 76 cents.

Zacks Rank: Patterson Companies has a Zacks Rank #3 which increases the predictive power of ESP; but when combined with a 0.00% ESP, it makes surprise prediction difficult.

Meanwhile, we caution against stocks with a Zacks Rank #4 or 5 (Sell-rated stocks) going into the earnings announcement, especially when the company is seeing negative estimate revisions.

Stocks to Consider

Here are some companies you may want to consider as our model shows they have the right combination of elements to post an earnings beat this quarter:

Air Methods (NASDAQ:AIRM) , with earnings ESP of +1.05% and a Zacks Rank #1.

CONMED (NASDAQ:CNMD) , with earnings ESP of +2.22% and a Zacks Rank #2.

Laboratory Corp. of America Holdings (NYSE:LH) , with earnings ESP of +.87% and a Zacks Rank #2.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .


CONMED CORP (CNMD): Free Stock Analysis Report

LABORATORY CP (LH): Free Stock Analysis Report

PATTERSON COS (PDCO): Free Stock Analysis Report

AIR METHODS CRP (AIRM): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.